TIVDAK (tisotumab vedotin-tftv) for injection
TIVDAK TM is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Medicines
A drug is any substance that causes a change in an organism’s physiology or psychology when consumed. Drugs are typically distinguished from food and substances that provide nutritional support. Consumption of drugs can be via inhalation, injection, smoking, ingestion, absorption via a patch on the skin, or dissolution under the tongue.
Sertraline hydrochloride
Sertraline hydrochloride tablets are a selective serotonin reuptake inhibitor (SSRI) for oral administration. Sertraline hydrochloride tablets are indicated for the treatment of major depressive disorder in adults.
Quality Choice Nasal Spray
Quality Choice Nasal Spray Active ingredient: Oxymetazoline hydrochloride 0.05% Purpose: Nasal decongestant Uses: Temporarily relieves nasal congestion due to: common cold hey fever upper respiratory allergies temporarily relieves sinus congestion and pressure shrinks swollen nasal membranes so you can breathe more freely Warnings Ask a doctor before use if you have heart disease high blood …
Savella® (milnacipran HCl)
Milnacipran hydrochloride is a selective norepinephrine and serotonin reuptake inhibitor. Savella is indicated for the management of fibromyalgia. Savella is not approved for use in pediatric patients.
Fludrocortisone Acetate Tablets USP
Fludrocortisone acetate tablets USP, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome.
TASIGNA® (nilotinib) capsules
Tasigna contains nilotinib, which belongs to a pharmacologic class of drugs known as kinase inhibitors. Tasigna is indicated for the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
PRISTIQ® (desvenlafaxine) Extended-Release Tablets
PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. PRISTIQ is indicated for the treatment of adults with major depressive disorder (MDD)